Adjuvant Imatinib in High-risk Gastrointestinal Stromal Tumor (GIST) With C-kit Mutation
NCT00278876
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
47
Enrollment
OTHER
Sponsor class
Conditions
Sarcoma
Gastrointestinal Stromal Tumors
Interventions
DRUG:
Imatinib mesylate (Glivec)
Sponsor
Asan Medical Center